QUALITY CHOICE VAGINAL ANTI-ITCH  MAXIMUM STRENGTH - benzocaine and resorcinol cream 
Chain Drug Marketing Association (CDMA)

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Drug Facts

Active ingredients:

Benzocaine 20%

Resorcinol 3%

Purpose

External analgesic

External analgesic

Use:

temporarily relieves itching.

Warnings

For external use only

When using this product avoid contact with the eyes

Stop use and ask a doctor if condition worsens or if symptoms persist for more than 7 days, or clear up and occur again within a few days, discontinue use of this product and consult a physician.

Do not apply over large areas of the body

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions:

Adults and Children 12 years of age and older

 
apply a fingertip amount (approximately 1 inch strip) to the affected area not more than 3 to 4 times daily

Children under 12 years

 
ask a doctor

Other information

store at 20°- 25°C (68°- 77°F)

Inactive ingredients

purified water, mineral oil, isopropyl palmitate, cetyl alcohol, PEG-100 stearate, glyceryl stearate, isopropyl myristate, lanolin, methyl-4 hydroxybenzoate, carbomer, fragrance, disodium EDTA, triethanolamine, propylene glycol, stearic acid corn oil, stearyl alcohol, vitamin A, E & D, aloe vera gel.

Principal Display Panel - 1 oz. Carton Label

QC®

QUALITY

CHOICE

*Compare to active
ingredients in VAGISIL
®
Maximum Strength

Maximum Strength

Vaginal Anti-Itch Cream

Medicated

20% Benzocaine | Resorcinol 3%

Long-Lasting Relief from:

Every Day Itching and Irritating Vaginal Conditions

Relieves Every Day Itch

QC®

QUALITY

CHOICE

Vaginal Anti-Itch Cream

Maximum Strength

1 OZ NET WT (28.4g)

Principal Display Panel - 1 oz. Carton Label

Principal Display Panel - 1 oz. Tube Label

QC®

QUALITY

CHOICE

*Compare to active ingredients in
VAGISIL
® Maximum Strength

Vaginal Anti-Itch Cream

Maximum Strength

20% Benzocaine | Resorcinol 3%

Long-Lasting Relief from:

Every Day Itching and Irritating Vaginal Conditions

1 OZ NET WT (28.4g)

Principal Display Panel - 1 oz. Tube Label
QUALITY CHOICE VAGINAL ANTI-ITCH   MAXIMUM STRENGTH
benzocaine and resorcinol cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:63868-965
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BENZOCAINE (UNII: U3RSY48JW5) (BENZOCAINE - UNII:U3RSY48JW5) BENZOCAINE200 mg  in 1 g
RESORCINOL (UNII: YUL4LO94HK) (RESORCINOL - UNII:YUL4LO94HK) RESORCINOL30 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
Aloe Vera Leaf (UNII: ZY81Z83H0X)  
Carbomer Copolymer Type B (Allyl Pentaerythritol Crosslinked) (UNII: 809Y72KV36)  
Cetyl Alcohol (UNII: 936JST6JCN)  
Edetate Disodium (UNII: 7FLD91C86K)  
Glyceryl Monostearate (UNII: 230OU9XXE4)  
Isopropyl Myristate (UNII: 0RE8K4LNJS)  
Isopropyl Palmitate (UNII: 8CRQ2TH63M)  
Lanolin (UNII: 7EV65EAW6H)  
Potassium Methylparaben (UNII: M64U971IB0)  
Mineral Oil (UNII: T5L8T28FGP)  
PEG-100 Stearate (UNII: YD01N1999R)  
Propylene Glycol (UNII: 6DC9Q167V3)  
Water (UNII: 059QF0KO0R)  
Stearic Acid (UNII: 4ELV7Z65AP)  
Stearyl Alcohol (UNII: 2KR89I4H1Y)  
Trolamine (UNII: 9O3K93S3TK)  
Vitamin A (UNII: 81G40H8B0T)  
Vitamin D (UNII: 9VU1KI44GP)  
.Alpha.-Tocopherol (UNII: H4N855PNZ1)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:63868-965-011 in 1 CARTON04/28/2014
128 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart34804/28/2014
Labeler - Chain Drug Marketing Association (CDMA) (011920774)
Establishment
NameAddressID/FEIBusiness Operations
Natural Essentials947484713MANUFACTURE(63868-965)

Revised: 1/2018
Document Id: cf4cdefd-b7bb-4d22-a4fe-d03b480f78bd
Set id: c86d96ac-9145-4b8e-a044-4338474cef00
Version: 2
Effective Time: 20180124
 
Chain Drug Marketing Association (CDMA)